Allarity Therapeutics, Inc. (NASDAQ: ALLR) announced it presented a Trial-in-Progress poster at the ESMO Gynaecological Cancers Congress 2026, held June ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE